Immunotherapy: A Conversation

More than 100 years ago, New York surgeon Dr. William Coley had the first hint of the immune system trying to attack and control cancer when he noticed that sarcoma tumors regressed in patients who had post-operative skin infections and high fevers. Coley experimented with the idea of treating cancer with heat-killed bacteria, but at the time there was very little understanding about what stimulates an immune response.


Immunotherapies activate the body’s immune system to fight cancer. We sat down with our own Steve Davidsen, Ph.D., vice president of oncology discovery, AbbVie, and Diane Hollenbaugh, Ph.D., senior director, oncology biologics, AbbVie, to look into AbbVie’s work in immunotherapies.